|
Rogers, Laura Q |
University Of Alabama At Birmingham |
Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors |
Supportive Care and Symptom Management, Fatigue |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Yennu, Sriram |
University Of Tx Md Anderson Can Ctr |
A Combination Therapy to Treat Cancer-Related Fatigue |
Supportive Care and Symptom Management, Fatigue |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Mao, Jun J |
Sloan-Kettering Inst Can Research |
Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE) |
Supportive Care and Symptom Management, Cognitive Dysfunction |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Mosher, Catherine E |
Indiana Univ-Purdue Univ At Indianapolis |
Acceptance and Commitment Therapy for Fatigue Interference in Metastatic Breast Cancer |
Supportive Care and Symptom Management, Fatigue |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Schenker, Yael |
University Of Pittsburgh At Pittsburgh |
Patient-centered and efficacious advance care planning in cancer: the PEACe comparative effectiveness trial |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Smith, Ellen Mary Lavoie |
University Of Alabama At Birmingham |
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study |
Supportive Care and Symptom Management, Neuropathy |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Shelby, Rebecca A |
Duke University |
Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis |
Supportive Care and Symptom Management, Pain |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Perkins, Susan M |
Indiana Univ-Purdue Univ At Indianapolis |
Evaluation of the Communication Plan Early through End-of-Life (COMPLETE) Intervention |
Supportive Care and Symptom Management, End of Life |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Washington, Karla |
Washington University |
Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care |
Supportive Care and Symptom Management, Caregiver Issues |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Hui, David |
University Of Tx Md Anderson Can Ctr |
Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients |
Supportive Care and Symptom Management, Other Supportive Care Issues |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Hui, David |
University Of Tx Md Anderson Can Ctr |
Strategies for Persistent Agitated Delirium in Palliative Care |
Supportive Care and Symptom Management, Cognitive Dysfunction |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Kolb, Noah Allan |
University Of Vermont & St Agric College |
Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy |
Supportive Care and Symptom Management, Neuropathy |
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Bylund, Carma L. |
University Of Florida |
Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators |
Supportive Care and Symptom Management, Geriatrics |
PAR-18-869: Modular R01s in Cancer Control and Population Sciences |
|
Geisler, Stefanie |
Washington University |
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy |
Supportive Care and Symptom Management, Neuropathy |
PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
|
Salvemini, Daniela |
Saint Louis University |
Fingolimod and Ozanimod for the treatment and prevention of chemobrain |
Supportive Care and Symptom Management, Cognitive Dysfunction |
PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
